References
- Smith E B. Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis. J Am Acad Dermatol 1993; 28: S24–S28
- Wortzel M H. A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product. Cutis 1982; 30: 258–61
- Fleming T R., Harrington D P., O'Brien P C. Designs for group sequential tests. Control Clin Trials 1984; 5: 348–61
- Katz H I., Bard J, Cole G W., et al. SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis. Cutis 1984; 34: 183–8
- Samson C, Peets E, Winter-Sperry R, . Clotrimazole/betamethasone dipropionate: an antifungal/steroid combination for treatment of cutaneous dermatophyte infections. Topical corticosteroids, H I. Maibach, C Surber, et al. Karger, Basel 1992; 318–34
- Evans E CV, James I GV, Seaman R A., et al. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin. Br J Dermatol 1993; 129: 437–42
- Reynolds R D., Boiko S, Lucky A W. Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone dipropionate (clotrimazole/betamethasone dipropionate). Am J Dis Child 1991; 145: 1224–5